Overall Women's Health 

~80% of women experience hormonal health issues during their lifetime. This includes conditions like:● PCOS● Endometriosis● PMS/PMDD● Fibroids● Thyroid disorders ● Menopause-related symptoms.Inner Balance

PCOS10–13% of women affected WHO Up to 70% undiagnosed WHOLeading cause of hormonal infertility affecting 30-50% of infertile women. WHO

Endometriosis1 in 10 reproductive age women affected (~190 million) worldwide WHO University of ExeterOnly ~40% diagnosed University of ExeterFound in 25–50% of infertile women WHOCan affect organs beyond reproductive system (e.g., lungs in ~12% of cases) UK Parliament

PMS & PMDDUp to 90% of women experience PMS UK ParliamentPMDD (severe form): ~1.6% globally (~31 million) Oxford University research ~90% of PMDD cases undiagnosed WHO University of ExeterSevere cases: Affect 13–18% of women with functional impairment Oxford University research 

Fibroids & Menstrual Conditions20–30% prevalence (fibroids) (Wang, 2023)Up to 70–80% of women develop fibroids by age 50 UK Parliament1 in 3 women experience heavy menstrual bleeding UK Parliament40% of women experience urinary incontinence RCOG

Thyroid & Hormonal Aging15% of women over 60 affected by thyroid dysfunction Inner Balance5.5% prevalence during pregnancy Inner Balance

Thyroid & Hormonal Aging19% of married women unable to conceive after one year CDC data13.4% of all women experience impaired fertility CDC data
Causes:● PCOS: 80–85% of anovulatory infertility cases ● Endometriosis: 30–50% of infertility cases● Thyroid disorders (5–11% in pregnancy)CDC data

MenopauseUp to 90% of women experience menopausal symptoms McKinsey~50% of lifetime bone loss occurs during menopause transition (Chen, 2023)

AdenomyosisGlobal prevalence in the general population is 1% (95%CI, 0%-2%)31% (95%CI, 10%-58%) among women experiencing infertility and a pooled prevalence of 41%-49% for those experiencing gynecologic symptoms (Wang, 2025)“For instance, among patients exhibiting clinical symptoms, the prevalence of endometriosis ranges from 25% to 66% [6, 7], while adenomyosis prevalence varies from 12% to 55% [6, 8]. Additionally, the prevalence of endometriosis in infertile women ranges from 22% to 91% [9, 10], whereas adenomyosis prevalence ranges from 4% to 89% [11, 12].”
Disclaimer: more difficult to claim these values on the website since there's been little research

Economic Impact

Link to McKinsey Report